02 June 2021 - Baby and children’s supplement manufacturer Bubs Australia (ASX:BUB) reported a dramatic 22 per cent increase in its share price yesterday, prompting market operator the ASX to approach the company for a justification. The infant formula producer has associated the price surge with no other reason but China’s new population strategy of encouraging families to have three children, boosting demand for Australian baby formula and other children-related supplements.